Search results
Alzheimer's drug from Eisai and Biogen rejected in Europe
AOL· 5 days ago(Reuters) -The European Union's drugs regulator has rejected Eisai and Biogen's Leqembi treatment for early Alzheimer's disease, saying the risk of serious brain swelling did not outweigh its ...